EDGAR Filing Documents for 0001104659-12-005918

Form 8-K - Current report:

SEC Accession No. 0001104659-12-005918

Filing Date

2012-02-01

Accepted

2012-02-01 17:16:17

Documents

Period of Report

2012-01-31

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a12-4013_18k.htm	8-K	29292
2	EX-4.1	a12-4013_1ex4d1.htm	EX-4.1	107269
3	EX-10.1	a12-4013_1ex10d1.htm	EX-10.1	1679567
4	EX-99.1	a12-4013_1ex99d1.htm	EX-99.1	12970
5	GRAPHIC	g40131mm01i001.jpg	GRAPHIC	4227
	Complete submission text file	0001104659-12-005918.txt		1836393

Mailing Address 5001 SOUTH MIAMI BOULEVARD SUITE 300 DURHAM NC 27703

Business Address 5001 SOUTH MIAMI BOULEVARD SUITE 300 DURHAM NC 27703 919 474 0020

TRANZYME INC (Filer) CIK: 0001274644 (see all company filings)